A GPR119 agonist (EC50 = 43.9 nM in CHO-K1 cells expressing human GPR119); inhibits T0901317-induced increases in SREBP-1 levels and increases activation of AMPK in HepG2 cells in a concentration-dependent manner; inhibits BCRP and OATP1B1 by 52 and 40%, respectively, at 3 μM